ARMS2 A69S polymorphism is associated with the number of ranibizumab injections needed for exudative age-related macular degeneration in a pro re nata regimen during 4 years of follow-up
- Valverde-Megías, A.
- Veganzones-de-Castro, S.
- Donate-López, J.
- Maestro-de-las-Casas, M.L.
- Megías-Fresno, A.
- García-Feijoo, J.
ISSN: 1435-702X, 0721-832X
Datum der Publikation: 2017
Ausgabe: 255
Nummer: 11
Seiten: 2091-2098
Art: Artikel